Osteoarthritis Trial, Recruiting NCT06423300 Sponsor: ZKR Orthopedics Inc Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT06423300
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are between 22 and 65 years old at the time of screening
  • People who have pain at the front of the knee caused by cartilage breakdown behind the kneecap, confirmed by MRI to be at a moderate-to-severe level (Modified Outerbridge score of 3 or higher)
  • People with a Body Mass Index (BMI) of 35 or below
  • People who weigh less than 300 pounds
  • People whose knee function score on a standard questionnaire (called the Anterior Knee Pain Score) is 70 or below out of 100, indicating meaningful difficulty
  • People whose pain level on a standard pain scale (Visual Analog Score) is 40 or above out of 100, indicating a notable level of pain
  • People who have already tried at least 6 months of non-surgical treatments — such as rest, bracing, physical therapy, targeted exercise, anti-inflammatory medications, or activity changes — without enough improvement

Who may not be able to join:

  • People whose cartilage breakdown behind the kneecap is rated at a mild level (Modified Outerbridge score of 2 or lower)
  • People who have significant pain or problems in the opposite knee that affect daily activities, stair climbing, or that require a walking aid
  • People who have a history of their kneecap slipping out of place or being unstable
  • People whose kneecap sits too high or too low in its groove (a condition called patella alta or patella baja)
  • People with a known measurement between two specific bony points in the knee (called TT-TG distance) of more than 20mm, which relates to kneecap alignment (confirm with trial site)
  • People who would need a cartilage grafting, cartilage transplantation, or bone marrow stimulation procedure at the same time as this trial procedure
  • People who have previously had a repair of a torn patellar tendon (the tendon connecting the kneecap to the shinbone)
  • People who have previously had a tibial tubercle realignment surgery or a full or partial knee replacement in the study knee
  • People who have had joint-altering surgery in the study knee — such as ligament reconstruction, meniscus repair, cartilage transplantation, or microfracture — within the 6 months before the planned trial procedure
  • People who have had arthroscopic knee surgery for joint washout, meniscus removal, cartilage cleaning, or loose body removal in the study knee within 3 months before the planned trial procedure
  • People with a current infection, bone infection, or a history of a joint infection in any joint
  • People who have rheumatoid arthritis, another form of inflammatory joint disease, or an autoimmune condition
  • People with a history of bone tissue death due to loss of blood supply (avascular necrosis) in any bone
  • People with a history of significant patellar tendon pain or a tear within the body of that tendon
  • People whose knee ligaments or tendons are not stable enough to support the trial device being studied (confirm with trial site)
  • People with significant ligament injury or meniscus tearing in the study knee (confirm with trial site)
  • People who have significant pain or problems with the main (thigh-to-shin) part of the study knee joint that affect daily activities, stair climbing, or that require a walking aid
  • People whose MRI or other imaging shows severe cartilage damage (Modified Outerbridge Grade 4) in the thigh-to-shin part of the study knee that may be the likely cause of their symptoms

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 9543033777

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
ZKR Orthopedics Inc
Registry
ClinicalTrials.gov
Start date
19 June 2024
Est. completion
1 September 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

24 month composite endpoint demonstrating non-inferiority of the LIFT System as compared to TTO.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov